Trial Profile
ATREUS Trial - A Phase II Study on the Activity of Trabectedin of Pretreated Epithelioid or Biphasic / Sarcomatoid Malignant Pleural Mesothelioma(MPM).
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 Jul 2022
Price :
$35
*
At a glance
- Drugs Trabectedin (Primary)
- Indications Malignant-mesothelioma
- Focus Therapeutic Use
- Acronyms ATREUS
- 22 Jan 2020 Status changed from active, no longer recruiting to completed.
- 24 Sep 2019 Planned End Date changed from 1 Jun 2019 to 1 Dec 2019.
- 24 Sep 2019 Planned primary completion date changed from 1 Jun 2019 to 1 Dec 2019.